Biggest News Aggregation in the World
📰 Current Reports News

Page 62 - Current Reports News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Current Reports. Real-time updates on events, politics, business and more.

Bristol Myers Squibb - Eight-Year Data for Opdivo Plus Yervoy Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

PRINCETON - Bristol Myers Squibb today announced that Opdivo plus Yervoy continued to demonstrate long-term survival results in the Phase 3 CheckMate -214 trial, reducing the risk of death by 28%...
United States South Korea Nizar Tannir Dana Walker Bristol Myers Squibb Drug Administration

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Demonstrates Long-Term Survival Benefits After Four Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma

Opdivo in combination with CABOMETYX reduced the risk of death by 23% in the first-line treatment of advanced renal cell carcinoma vs. sunitinib Four-year results demonstrating continued benefits...
United States South Korea Dana Walker Amy Peterson Bristol Myers Squibb Maria Teresa Bourlon

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science